Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Breast Neoplasms 529Neoplasms 494Carcinoma, Non-Small-Cell Lung 404Prostatic Neoplasms 309Colorectal Neoplasms 293Lung Neoplasms 272Neoplasm Metastasis 225Leukemia, Myeloid, Acute 214Ovarian Neoplasms 197Pancreatic Neoplasms 188Multiple Myeloma 181Squamous Cell Carcinoma of Head and Neck 141Recurrence 139Stomach Neoplasms 137Brain Neoplasms 131Melanoma 129Carcinoma, Hepatocellular 128Endometrial Neoplasms 118Triple Negative Breast Neoplasms 116Glioblastoma 112Precursor Cell Lymphoblastic Leukemia-Lymphoma 108Hematologic Neoplasms 99Head and Neck Neoplasms 99Urinary Bladder Neoplasms 97Carcinoma, Renal Cell 97Lymphoma 95Glioma 90Sarcoma 89Esophageal Neoplasms 87Lymphoma, Large B-Cell, Diffuse 84

Interventions

TP protocol 1Radiotherapy 1Lomustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Recurrence, Local × 90 days × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT07100730 2026-04-16

IPAX BrIGHT

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 3 Recruiting
50 enrolled
CNS

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡